Drug Type Small molecule drug |
Synonyms- |
Target |
Action antagonists |
Mechanism σ1 receptor antagonists(Sigma opioid receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC19H24ClN3O2 |
InChIKeyDWMXOHFJNKUDPZ-UHFFFAOYSA-N |
CAS Registry2448691-41-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | United States | 12 Apr 2024 |